Hoe verhoudt A150840's PS Ratio zich tot zijn concurrenten?

Insufficient data to answer this question

Hoe verhoudt A150840's PS Ratio zich tot andere bedrijven in de KR Medical Equipment industrie?

Insufficient data to answer this question

Wat is A150840's PS Ratio vergeleken met zijn Fair PS Ratio? Dit is de verwachte PS Ratio, rekening houdend met de verwachte winstgroei van het bedrijf, winstmarges en andere risicofactoren.

Insufficient data to answer this question

Wat is de reële prijs van A150840 als we kijken naar de toekomstige kasstromen? Voor deze schatting gebruiken we een Discounted Cash Flow-model.

Insufficient data to answer this question

Wat is de 12-maandsprognose van de analisten en hebben we enig statistisch vertrouwen in het consensuskoersdoel?

Insufficient data to answer this question

IntroMedic (KOSDAQ:A150840) - Aandelenkoers, Nieuws & Analyse

A150840 Overzicht aandelen

IntroMedic Co., Ltd. develops and supplies medical equipment in South Korea and internationally.

Over het bedrijf

A150840 fundamentele analyse
Sneeuwvlok Score
Waardering	0/6
Toekomstige groei	0/6
Prestaties in het verleden	0/6
Financiële gezondheid	6/6
Dividenden	0/6

Beloningen

Risicoanalyse

IntroMedic Co., Ltd. Concurrenten

DIO

KOSDAQ:A039840

₩239.1b

Boditech Med

KOSDAQ:A206640

₩334.2b

Vieworks

KOSDAQ:A100120

₩214.4b

DRTECH

KOSDAQ:A214680

₩223.4b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor IntroMedic
Historische aandelenkoersen
Huidige aandelenkoers	₩5,850.00
52 Week Hoogtepunt	₩8,220.00
52 Week Laag	₩2,460.00
Bèta	0.40
11 maand verandering	0%
3 maanden verandering	-4.26%
1 Jaar Verandering	136.36%
33 jaar verandering	6.36%
5 jaar verandering	70.31%
Verandering sinds IPO	105.26%

Recent nieuws en updates

Recent updates

IntroMedic's (KOSDAQ:150840) Stock Price Has Reduced 68% In The Past Three Years

Mar 11

IntroMedic (KOSDAQ:150840) Is Carrying A Fair Bit Of Debt

Jan 17

What Type Of Returns Would IntroMedic's(KOSDAQ:150840) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Nov 24

Rendement voor aandeelhouders

	A150840	KR Medical Equipment	KR Markt
7D	0%	-1.9%	-1.0%
1Y	136.4%	12.3%	3.2%

Prijsvolatiliteit

Is A150840's price volatile compared to industry and market?
A150840 volatility
A150840 Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	7.0%
Market Average Movement	5.5%
10% most volatile stocks in KR Market	11.6%
10% least volatile stocks in KR Market	2.6%

Over het bedrijf

Opgericht	Werknemers	CEO	Website
2004	54	Yong Seok Cho	www.intromedic.com

IntroMedic Co., Ltd. Samenvatting

Hoe verhouden de winst en inkomsten van IntroMedic zich tot de beurswaarde?
A150840 fundamentele statistieken
Marktkapitalisatie	₩223.67b
Inkomsten(TTM)	-₩15.52b
Inkomsten(TTM)	₩8.01b

27.9x

P/S-verhouding

-14.4x

Koers/Winstverhouding

Is A150840 overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
A150840 resultatenrekening (TTM)
Inkomsten	₩8.01b
Kosten van inkomsten	₩3.43b
Brutowinst	₩4.59b
Overige uitgaven	₩20.11b
Inkomsten	-₩15.52b

Laatst gerapporteerde inkomsten

Mar 31, 2022

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	-405.99
Brutomarge	57.23%
Nettowinstmarge	-193.75%
Schuld/Eigen Vermogen Verhouding	16.3%

Hoe presteerde A150840 op de lange termijn?

Bekijk historische prestaties en vergelijking

A150840 Overzicht aandelen

Beloningen

Risicoanalyse

IntroMedic Co., Ltd. Concurrenten

KOSDAQ:A039840

₩239.1b

KOSDAQ:A206640

₩334.2b

KOSDAQ:A100120

₩214.4b

KOSDAQ:A214680

₩223.4b

Prijsgeschiedenis en prestaties

Recent nieuws en updates

IntroMedic Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 999.99975 million.

IntroMedic Co., Ltd. has filed a Follow-on Equity Offering in the amount of KRW 999.99975 million.

IntroMedic Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 999.9978 million.

Full year 2020 earnings released: ₩262 loss per share (vs ₩893 loss in FY 2019)

DSP Corporation entered into an agreement to acquire EMnI Co., Ltd. (KOSDAQ:A083470) from Hans Eng Corp. and IntroMedic Co., Ltd. (KOSDAQ:A150840) for KRW 3.1 billion.

IntroMedic Co., Ltd. announced that it expects to receive KRW 19.99999982 billion in funding from AMB 2000DC WON INC. and another investor

Recent updates

IntroMedic Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 999.99975 million.

IntroMedic Co., Ltd. has filed a Follow-on Equity Offering in the amount of KRW 999.99975 million.

IntroMedic Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 999.9978 million.

Full year 2020 earnings released: ₩262 loss per share (vs ₩893 loss in FY 2019)

DSP Corporation entered into an agreement to acquire EMnI Co., Ltd. (KOSDAQ:A083470) from Hans Eng Corp. and IntroMedic Co., Ltd. (KOSDAQ:A150840) for KRW 3.1 billion.

IntroMedic Co., Ltd. announced that it expects to receive KRW 19.99999982 billion in funding from AMB 2000DC WON INC. and another investor

IntroMedic's (KOSDAQ:150840) Stock Price Has Reduced 68% In The Past Three Years

New 90-day low: ₩2,095

New 90-day low: ₩2,275

IntroMedic Co., Ltd., Annual General Meeting, Mar 25, 2021

New 90-day low: ₩2,850

IntroMedic (KOSDAQ:150840) Is Carrying A Fair Bit Of Debt

New 90-day high: ₩3,560

What Type Of Returns Would IntroMedic's(KOSDAQ:150840) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

New 90-day high: ₩3,020

IntroMedic Co., Ltd. announced that it has received KRW 4.5 billion in funding from FIT Technology Co., Ltd., and another investor

New 90-day low - ₩1,970

Rendement voor aandeelhouders

Prijsvolatiliteit

Over het bedrijf

IntroMedic Co., Ltd. Samenvatting

27.9x

-14.4x

Inkomsten en omzet